Matt McGraner - 13 Mar 2026 Form 4 Insider Report for NexPoint Residential Trust, Inc. (NXRT)

Role
Executive VP and Chief Investment Officer
Signature
/s/ Paul Richards as attorney-in-fact for Matthew R. McGraner
Issuer symbol
NXRT
Transactions as of
13 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 21:03:58 UTC
Previous filing
13 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McGraner Matt Executive VP and Chief Investment Officer 300 CRESCENT COURT, SUITE 700, DALLAS /s/ Paul Richards as attorney-in-fact for Matthew R. McGraner 17 Mar 2026 0001636187

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXRT Common Stock Options Exercise +22,350 +7.1% 339,171 13 Mar 2026 Direct F1
transaction NXRT Common Stock Tax liability -9,837 -2.9% $25.73* 329,334 13 Mar 2026 Direct
holding NXRT Common Stock 13,054 13 Mar 2026 By 401(k) plan
holding NXRT Common Stock 16,986 13 Mar 2026 By limited liability company F2
holding NXRT Common Stock 108,630 13 Mar 2026 By Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXRT Restricted Stock Units Options Exercise -22,350 -25% $0.000000* 67,050 13 Mar 2026 Common Stock 22,350 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Residential Trust, Inc.
F2 These shares are held by a limited liability company in which Mr. McGraner owns an indirect minority interest. Mr. McGraner disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F3 These shares are held in a trust. Mr. McGraner is the trustee of the trust. Mr. McGraner disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F4 On March 13, 2024, the reporting person was granted 111,752 restricted stock units which vested one-fifth on March 13, 2025 and one-fifth on March 13, 2026, and which will vest one-fifth on March 13, 2027, one-fifth on March 13, 2028, and one-fifth on March 13, 2029. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash.

Remarks:

Executive VP and Chief Investment Officer